About 6.7 percent of children under 18 have a diagnosed eye condition, most commonly refractive errors, such as nearsightedness, farsightedness, and astigmatism. Clinical trials can improve outcomes for children by preventing lifelong visual impairment and shaping their overall development. Yet, Black children are often left out of pediatric eye disease trials, and it’s keeping them out of opportunities for treatment.
Pediatric eye disease encompasses a range of conditions affecting children’s vision, including refractive errors, congenital cataracts, retinopathy of prematurity, amblyopia (lazy eye), and strabismus (crossed eyes).
These conditions can significantly affect a child’s development, impacting not only vision but also learning, social interactions, and overall quality of life. Early detection and intervention are critical, as many of these diseases can lead to long-term visual impairment if left untreated.
RELATED: What to Know Before Enrolling Your Child in a Clinical Trial
In a research study that focused on the prevalence of lazy eye (amblyopia) and cross-eyes (strabismus) in white and Black American children, researchers found that manifest strabismus occurred in 3.3 percent of white children compared to 21 percent of Black American children.
The study shows the prevalence of amblyopia was found to be less than 2 percent in both groups. These findings highlight significant disparities in the prevalence of strabismus, which may be influenced by genetic, environmental, and socioeconomic factors.
These differences underscore the need for targeted interventions and increased awareness in communities with higher rates of strabismus to ensure that all children receive timely evaluations and appropriate care.
Addressing these disparities requires not only public health initiatives but also culturally sensitive outreach and education to promote eye health and access to care for all children.
While over time the rates have improved, previously, Black children were most commonly underrepresented in pediatric eye clinical trials.
Researchers predicted that Black American children would be underrepresented in clinical trials because of a legacy of exploitation of Black people in unethical medical studies.
For example, the infamous Tuskegee experiment, in which Black men with syphilis were left to suffer without treatment so scientists could study the effects of the disease.
This mistrust in the medical community has impacted many Black Americans in receiving medical treatments. Not to mention, there is also a lack of targeted outreach and education about clinical trials in Black communities, leading to lower awareness of available opportunities.
The good news is that this can be changed, and medical professionals can begin to see more Black Americans engaging in clinical trials. But how can this be achieved? To address these disparities and ensure that Black children are adequately represented in pediatric eye disease research, Medical providers should build trust within the communities where Black Americans reside through outreach programs to bridge the gap and combat misinformation.
When medical providers engage in community work, community members and providers can build strong rapport; providers can also raise awareness and encourage participation in clinical trials.
Another way to increase participation is for medical providers to create educational materials that resonate with Black families and demystify clinical trials. This approach provides formal education and a safe space while emphasizing the importance of participation and addressing their concerns. Both actions will increase Black Americans’ participation in clinical trials and better support those in need.
RELATED: What Black Parents Should Know Before Joining a Clinical Trial
These actions matter, and efforts should focus on ensuring equitable access to eye care and research participation across all demographics. Pediatric eye disease presents significant challenges, particularly for Black children who face both biological and social disparities.
A collaborative approach will enrich scientific understanding and empower Black American families to actively participate in their children’s health journeys. Ultimately, by fostering inclusivity and trust, we can ensure that all Black American children will have the opportunity for optimal vision and health outcomes.
By subscribing, you consent to receive emails from BlackDoctor.com. You may unsubscribe at any time. Privacy Policy & Terms of Service.
